Ocugen (OCGN) Operating Income (2014 - 2026)
Ocugen (OCGN) posted Operating Income of -$17.8 million for Q1 2026, down 4.97% on a QoQ basis from -$17.0 million in Q4 2025, and down 23.02% year-over-year from -$23.2 million in Q1 2025.
Ocugen (OCGN) Operating Income (2014 - 2026) Analysis & Trends
Ocugen's Operating Income history runs 13 years deep, the most recent figure standing at -$17.8 million for Q1 2026.
- Quarterly Operating Income fell 23.02% year-over-year to -$17.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$66.3 million (down 16.15% YoY) and the FY2025 annual result came in at -$62.9 million, down 14.9% from the prior year.
- Operating Income was -$17.8 million for Q1 2026 at Ocugen, down from -$17.0 million in the prior quarter.
- Across five years, Operating Income topped out at -$11.5 million in Q4 2023 and bottomed at -$25.1 million in Q3 2022.
- A 5-year average of -$17.1 million and a median of -$17.0 million in 2025 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income sank 169.66% — and 2023, when it surged 50.65%.
- Ocugen's Operating Income stood at -$23.4 million in 2022, then surged by 50.65% to -$11.5 million in 2023, then retreated by 20.09% to -$13.8 million in 2024, then dropped by 22.8% to -$17.0 million in 2025, then declined by 4.97% to -$17.8 million in 2026.
- Business Quant data shows OCGN's Operating Income at -$17.8 million in Q1 2026, -$17.0 million in Q4 2025, and -$17.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Ocugen | 63.79 Mn | 63.79 Mn | - | -17.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.84 Mn |
| Dec 31, 2025 | -17.00 Mn |
| Sep 30, 2025 | -17.63 Mn |
| Jun 30, 2025 | -13.80 Mn |
| Mar 31, 2025 | -14.50 Mn |
| Dec 31, 2024 | -13.84 Mn |
| Sep 30, 2024 | -13.25 Mn |
| Jun 30, 2024 | -15.45 Mn |
| Mar 31, 2024 | -12.22 Mn |
| Dec 31, 2023 | -11.53 Mn |
| Sep 30, 2023 | -12.43 Mn |
| Jun 30, 2023 | -23.54 Mn |
| Mar 31, 2023 | -18.04 Mn |
| Dec 31, 2022 | -23.36 Mn |
| Sep 30, 2022 | -25.11 Mn |
| Jun 30, 2022 | -21.58 Mn |
| Mar 31, 2022 | -19.03 Mn |
| Dec 31, 2021 | -14.57 Mn |
| Sep 30, 2021 | -10.79 Mn |
| Jun 30, 2021 | -25.61 Mn |